Elizabeth J. Boland
Elizabeth J. Boland's purchase track record
Elizabeth J. Boland has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/23/2022 | PLCE | $107K | -12.4% | -24.8% | -14.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Children's Place Secures Loan from Saudi Family Office. Children's Place has engaged an adviser and secured a loan from a Saudi family office. This move suggests the company is actively restructuring its balance sheet or seeking new capital sources. The stock currently trades near its 52-week low, reflecting the significant financial challenges the retailer faces.
Transaction History
| BFAM | ▲ Buy | Grant | 9,900 | $0 | 3/4/2026 | View on chart |
| BFAM | ▲ Buy | Grant | 3,847 | $0 | 2/24/2026 | View on chart |
| BFAM | ▼ Sell | Tax Withholding | 1,283 | $92K | 2/24/2026 | View on chart |
| BFAM | ▼ Sell | Tax Withholding | 2,422 | $174K | 2/24/2026 | View on chart |
| BFAM | ▼ Sell | Open Market | 3,500 | $463K | 5/27/2025 | View on chart |
| BFAM | ▼ Sell | Open Market | 5,000 | $651K | 3/5/2025 | View on chart |
| BFAM | ▲ Buy | Grant | 4,224 | $0 | 3/5/2025 | View on chart |
| BFAM | ▼ Sell | Tax Withholding | 1,707 | $217K | 2/25/2025 | View on chart |
| BFAM | ▼ Sell | Open Market | 3,455 | $477K | 8/15/2024 | View on chart |
| BFAM | ▼ Sell | Open Market | 4,851 | $654K | 8/14/2024 | View on chart |
| BFAM | ▼ Sell | Open Market | 1,503 | $204K | 8/14/2024 | View on chart |
| BFAM | ▲ Buy | Option Exercise | 2,786 | $269K | 8/7/2024 | View on chart |
| BFAM | ▼ Sell | Tax Withholding | 2,303 | $302K | 8/7/2024 | View on chart |
| BFAM | ▲ Buy | Option Exercise | 2,714 | $212K | 8/7/2024 | View on chart |
| BFAM | ▼ Sell | Tax Withholding | 1,982 | $260K | 8/7/2024 | View on chart |
| BFAM | ▲ Buy | Grant | 4,756 | $0 | 3/4/2024 | View on chart |
| BFAM | ▼ Sell | Open Market | 520 | $58K | 2/28/2024 | View on chart |
| BFAM | ▼ Sell | Open Market | 3,905 | $442K | 2/28/2024 | View on chart |
| BFAM | ▼ Sell | Open Market | 11,215 | $1.3M | 2/28/2024 | View on chart |
| PLCE | ▲ Buy | Grant | 6,980 | $0 | 2/5/2024 | View on chart |
| BFAM | ▲ Buy | Grant | 7,052 | $0 | 2/24/2023 | View on chart |
| PLCE | ▲ Buy | Grant | 3,287 | $0 | 1/30/2023 | View on chart |
| PLCE | ▲ Buy | Open Market | 2,200 | $107K | 3/23/2022 | View on chart |
| BFAM | ▼ Sell | Open Market | 2,000 | $270K | 3/16/2022 | View on chart |
| BFAM | ▲ Buy | Grant | 10,120 | $652K | 2/25/2022 | View on chart |
| BFAM | ▼ Sell | Open Market | 2,846 | $370K | 2/4/2022 | View on chart |
| PLCE | ▲ Buy | Grant | 1,979 | $0 | 1/31/2022 | View on chart |
| BFAM | ▼ Sell | Open Market | 6,000 | $900K | 10/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
BMO Lowers Bright Horizons Price Target to $83
BMO Capital maintained its Outperform rating on Bright Horizons but lowered its price target to $83. This action follows a broader review of consumer discretionary education stocks after their second-quarter results. The new target sits below the current average analyst estimate of $88.11, reflecting a more conservative outlook for the company's near-term performance.
BMO Lowers Bright Horizons Price Target to $83. BMO Capital maintained its Outperform rating on Bright Horizons but lowered its price target to $83. This action follows a broader review of consumer discretionary education stocks after their second-quarter results. The new target sits below the current average analyst estimate of $88.11, reflecting a more conservative outlook for the company's near-term performance.